Action of estrogen receptors Rev Arg de Anat Clin; 2012, 4 (2): 65-69__________________________________________________________________________________________
Review UPDATE ON THE MECHANISM OF ACTION OF ESTROGEN RECEPTORS Ieda Millas, Bianca M. Liquidato, Mirna D. Barros Department of Morphology. Santa Casa School of Medical Sciences – São Paulo, SP. Brazil
and tissues, either or not directly related to reproduction. As in other regulatory processes, the
Los mecanismos de acción de los receptores
mechanisms of receptor-ligand binding are crucial to
estrogénicos (ER) han sido estudiados debido a sus
enable the action of the estrogen hormone that will
importantes funciones en el crecimiento celular y la
ultimately produce effects in the cellular metabolism.
diferenciación de varios órganos y tejidos, relacio-
Although extensively studied, the mechanisms of
nados o no con la reproducción. Como en otros
action of estrogen receptors are not completely
procesos regulatorios, los mecanismos de ligados a
unraveled. The present study is a literature review on
receptor son cruciales para permitir la acción de los
the mechanism of action of the ER-α and ER-β in the
estrógenos que finalmente producirían efectos en el
human body. The knowledge of the location and
metabolismo celular. Aunque muy estudiados, los
concentrations of the ER in different tissues is
mecanismos de acción de los receptores estrogénicos
essential to determine specific treatments for different
no han sido completamente desentrañados. El
pathologies, such as breast cancer. Moreover, in non-
presente estudio es una revisión de la literatura sobre
reproductive tissues, such as the nasal conchae
el mecanismo de acción de ER-α y ER-β en el cuerpo
mucosa, the presence of ER-α and ER-β may explain
humano. El conocimiento de la localización y
the variations in secretory activity of the nasal mucosa
concentraciones de ER en diferentes tejidos es
according to hormonal variability. ER neuro-protective
esencial para determinar tratamientos específicos para
and anti-inflammatory actions in the central nervous
diferentes patologías, tales como cáncer de mama.
system, as well as its allergic-response function in the
Más aún, en tejidos no reproductivos, tales como la
epithelium of the conjunctiva are also considered and
mucosa de los cornetes nasales, la presencia de ER-α
may apply to other studies concerning the diagnosis,
y ER-β podría explicar las variaciones en la actividad
drugs development and clinical treatments of different
secretora acorde con la variación hormonal. También
diseases, related to hormonal actions.
se consideran las acciones ER neuro-productivas y antinflamatorias en el sistema nervioso central al igual
Keywords: estrogen, hormones, estrogen receptor,
que su función de respuesta alérgica en el epitelio de
la conjuntiva y podrían aplicarse a otros estudios referidos al diagnóstico, desarrollo de drogas y el tratamiento de diferentes enfermedades asociados a acciones hormonales. Palabras clave: estrógenos, hormonas, receptores estrogénicos, fisiología, mecanismo * Correspondence to: Ieda Millas, Rua Dr. Diogo de Faria, 1087 – 1009, São Paulo, SP. Brazil. [email protected] ABSTRACT
The action mechanisms of estrogen receptors (ER)
Received: 28 May, 2012. Revised: 27 June, 2012.
have been studied due to their important functions in
Accepted: 2 July, 2012.
cellular growth and differentiation in several organs
Todos los derechos reservados. Reg. Nº: 5024555 www.anatclinar.com.ar
Action of estrogen receptors Rev Arg de Anat Clin; 2012, 4 (2): 65-69__________________________________________________________________________________________
INTRODUCTION
following key words were used in the survey of the literature: estrogen, hormones, estrogen
Estrogen is a hormone related to cell growth and
receptor, physiology, and mechanism. Papers
differentiation in many organs and tissues.
were selected for this review regarding as
It acts mainly in the regulation of cellular
inclusion criteria, those in English language and
human researches. And as exclusion criteria
intranuclear specific protein receptors (Enmark
papers related to cancer or any proliferative
and Gustafsson, 1999; Green et al, 1986;
Katzenellenbogen et al, 2000; Kuiper et al, 1996). Estrogen receptors (ER) are homodimeric nuclear receptor protein belonging to the super family of nuclear receptors that bind to liposoluble
hormones and interact with specific response elements of DNA. In the absence of hormones,
Estrogen receptors molecular structure and
inhibitory proteins, but when attached to their
Estrogen receptor α and ER-β are formed by
ligands may be taken to the nucleus and activate
amino acid sequences where the N-terminal
transcription of target genes. There are two
region contains one or more transcriptional
estrogen receptor isoforms, designated as alpha
activation domains, the central region has binding
and beta, which have homologous amino acid
domains with the "zinc fingers" DNA and the C-
sequences, particularly differing in the N-terminal
region (Enmark and Gustafsson, 1999; Green et
chromosome 14 q 22-24 region and the ER-α
Mosselman, 1996; Paech et al, 1997).
The classical estrogen receptor, which is called
chromosome 6 (Green et al, 1986; Gruber et al,
alpha, was described in 1962 by Jensen. In 1986
2004; Kuiper et al, 1996; Paech et al, 1997).
its genetic structure was cloned and defined by
When estrogen binds to ER, these monomers
Green et al. In 1994, the report of a patient
become dimers, and are coupled to specific
having a genetic mutation with absence of the
regions of DNA called estrogen and AP-1 sites
receptor alpha (ER-α), and showed changes
responsive elements, in which may or may not
such as osteoporosis and decreased fertility,
occur the gene transcription. Both types of
annulled the hypothesis that the lack of estrogen
receptors can act in different ways in the DNA
receptor alpha could be lethal .This fact led to the
(Katzenellenbogen et al, 2000; Kuiper et al, 1996;
discovery of a second type of receptor, called
Paech et al, 1997). Studies have shown that
beta (ER-β) by Kuiper et al in 1996. Thus,
changes in the structures of the receptors and
several studies have followed regarding the
their affinity for certain co-activators (enzymes of
existence of these two isoforms, with high
specific actions) are directly related to their
specificity and affinity in humans, a phenomenon
functions. Depending on the dimer formed
which allows the selective action of the hormone
(receptor + co-activator) the response in the
in different tissues (Fchsjauger-mayrl et al, 2002;
target gene will be different (Amstead et al, 1997;
Gruber et al, 2004; Katzenellenbogen et al, 2000;
Bernheimer and Soskin, 1942; Jensen, 1962;
Kian et al, 2004; Millas et al, 2010; Mosselman,
1996; Soskin and Bernheimer, 1939 ; Taylor and
The action of the receptors depends on a
Azzawi, 2000; Tiwari-Woodruff et al, 2007).
combination of the receptor, its binding factors
In this article we will discuss the mechanisms of
and the co-activating or modulating proteins
action of estrogen receptors, due to its
(Katzenellenbogen et al, 2000; Kuiper et al, 1996;
importance in tissue growth, differentiation and
Paech et al, 1997). These modulators may have
metabolism in reproductive organs and in other
activity that can be agonist and antagonist in the
DNA, so the same receptor can express different actions in different cells (Amstead et al, 1997). The activities related to these modulators among different receptor ligans α and β show distinct
MATERIAL AND METHOD
pharmacological actions on their target genes. For example, drugs such as tamoxifen,
This study consisted of a review of the literature
tetrahidrocriseno 2-fenilbenzofuram have an
over the last sixteen years, indexed in Pubmed,
agonist activity to α-type receptors, but
Medline and Scielo, covering papers relating to
antagonist to the β, this is due to differences in
estrogen receptors and steroid hormones. The
Todos los derechos reservados. Reg. Nº: 5024555 www.anatclinar.com.ar
Action of estrogen receptors Rev Arg de Anat Clin; 2012, 4 (2): 65-69__________________________________________________________________________________________
contributing to distinct and specific transcriptional
Katzenellenbogen et al, 2000 exemplify the
activities (Amstead et al, 1997; Bhagu et al,
contrary action of the receptors, where tamoxifen
2008; Kian et al, 2004; McDonnell, 2004).
has both an agonistic activity with the ER-α and antagonistic activity with ER-β, depending on the
Estrogen receptors expression
receptor. The differences in the amino-terminal
Literature describes a difference of expression of
regions of ER-α and ER-β contribute to distinct
ER in various tissues. They are present and
and specific transcriptional activities, as long as
playing important roles in the reproductive organs
both receptors have different distributions and
concentrations in the tissues. The respective
Fchsjauger-Mayrl et al, 2002; Ishunina et al,
interactions or activities between these two
2000; Millas et al, 2010; Tiwari-Woodruff et al,
receptors can generate significant differences in
2007) . For example, the ER-β has a higher
biological tissue responses (Kian et al, 2004).
expression in organs such as brain and adrenal,
A repressor protein of estrogen receptor activity
and ER-α in the uterus and breast. Both are
(REA) competes with the co-activator of these
abundantly expressed in reproductive system,
receptors. REA represents an example of a
while the ER-β is found in high concentrations in
protein which increases the potency of two
tissues that do not produce or are not estrogen-
inhibitors of ER. For example, the protein
dependent, suggesting that different receptors
quinone reductase (QR), present in the ER,
participate in biochemical processes in different
which undergoes an "up-regulation" in the
organs. The expression of ER-α is not related to
the β and vice versa indicating that they are
antagonist action to estrogen), suffers a
involved in independent mechanisms of action
suppression of its activity when bound to
(Katzenellenbogen et al, 2000; Paech et al, 1997;
estrogen (Amstead et al, 1997; Bhagu et al,
2008). The anti-estrogens have a higher stimulus
The specificity of the receptors’ cellular action is
through QR by ER-β than ER-α. Most genes
associated with different concentrations in these
under the regulation of estrogen receptors seem
tissues and with different genetic sites related to
to suffer an "up-regulation" by estrogen (Bhagu et
them in the cells of these tissues (Amstead et al,
1997; Katzenellenbogen et al, 2000; Kian et al,
Thus, the balance in the performance of ER’s
2004). The actions of these two subtypes and
tissular functions depends on a complex network
their ligands depend on a ligand-induced
of factors; co-activators, co-repressors, estrogen
conformation for ER-α and ER-β. For example,
and anti-estrogen concentration and the affinity of
when estrogen binds to a greater amount of ER-
each direct transcriptional receptor and the
β, the activity of ER-α is inhibited (Bhagu et al,
indirect genetic action, repressing or activating
2008). Moreover, the behavior of each subtype of
response elements in DNA. The knowledge of
ER varies within the same tissue. Ishunina et al
ER-α and ER-β regarding their location and their
(2000) observed "up-regulation" of the ER-β and
concentration in different tissues becomes
"down-regulation" of α in the same cell group
essential for certain medical treatments as in the
subjected to estrogen, ie, ER have different and
case of breast cancer, where, depending on the
specific transcriptional activities, in addition to
predominant receptor, selective modulators of ER
several tissue responses, due its peculiar
such as tamoxifen (Kian et al, 2004; McDonnell,
concentration and distribution in each tissue.
Gruber et al (2004) and Yang et al (2004) also observed
Estrogen receptors in non reproductive
transcriptional affinity, that is affinity in binding to
In organs not associated with reproduction, as in
the mucosa of inferior nasal conchae the
The selective modulators of estrogen receptors
presence of both receptors, ER-α and ER-β was
such as tamoxifen and raloxifene show both the
observed in the nucleus and cytoplasm of cells of
the glandular epithelium of the lamina propria and
depending on the type of tissue, and show tissue
respiratory epithelium (Millas et al, 2010; Millas et
selectivity. The ER-α has a more effective
al 2011; Shirasaki et al 2004). This may explain
response to estradiol than the ER-β in activation
the hormonal action on the nasal secretory
with the estrogen response element present in
activity and possibly the future use of drugs with
the DNA. Thus, the ER-β is more effective in the
hormones to stimulate the nasal secretion in
activation of element AP-1 with these modulators,
cases of atrophic rhinitis, as it was originally
compared to the alpha (Katzenellenbogen et al,
proposed in 1942 by Bernheimer and Soskin,
2000; Kian et al, 2004; McDonnell, 2004).
who examined the local effect of estrogen on nasal mucosa for the treatment of patients with
Todos los derechos reservados. Reg. Nº: 5024555 www.anatclinar.com.ar
Action of estrogen receptors Rev Arg de Anat Clin; 2012, 4 (2): 65-69__________________________________________________________________________________________
atrophic rhinitis and observed an increase of
Fchsjauger-Mayrl G, Nepp J, Schneeberger C,
vascularization and gland secretion of the coated
Sator M, Dietrich W, Wedrich A, Huber J,
nasal epithelium in the studied cases. In the
Tschuffuel W. 2002. Identification of estrogen
same line, Caruso et al, 2003, observed better
and progesterone receptor mRNA expression
features of the nasal epithelium in women treated
in the conjunctiva of premenopausal women.
with hormones, through the cytology index of
Green S, Walter P, Kumar V, Krust A, Bonert JM,
Similarly, ERs participate in other organs’
Argos P, Chambon P. 1986.Human oestrogen
functions. ERs’ different actions in the central
nervous system are described by observation
homology to v-erb-A. Nature 320: 134-139.
that the ER-α has anti-inflammatory activity and
Gruber JC, Gruber DM, Gruber IML, Wieser F,
beta has neuroprotective activity through
Huber JC. 2004. Anatomy of the estrogen
reduction of demyelination and axons preserving
response element. Trends Endocrinol Metab
(Tiwari-Woodruff et al, 2007). In the conjunctival
epithelium, the ERs influence the allergic
Ishunina TA, Kruijver FPM, Balesar R, Swaab
response, since they act in the maturation of
DF. 2000. Differential expression of estrogen
goblet cells and cells from the respiratory
receptor and immunoreactivity in the
epithelium as well as influencing the balance of
human supraoptic nucleus in relation to sex
secretion and absorption of aqueous humor, with
and aging. J Clin Endocrinol Metab 85: 3283-
an important role in the development of glaucoma
Jensen EV. 1962. On the mechanism of estrogen
This way, as final considerations, we remark the
action. Perspectives in Biology and Medicine 6:
importance of studying the mechanism of action
of estrogen receptors in different organs and
Katzenellenbogen BG, Choi I, Delage-Mourrow R, Ediger TR, Martini PG, Montana M, Sun J,
depending on the expression and the predomin-
Weis K, Katzenellenbogen JA. 2000. Molecular
ance of one or another subtype. As above
mentioned, the study of their functions can
Ligands and Receptor Pharmacology. J Steroid
contribute significantly to the understanding of
the pathophysiology of certain diseases and for
Kian Tee M, Rogatsky I, Tzagarakis-Foster C,
future advances in treating others, like atrophic
Cvoro A, An J, Christy RJ, Yamamoto KR, Leitman DC. 2004. Estradiol and Selective Estrogen Receptor Modulators Differentially Regulate
Receptors alpha e beta. ASBOC 15: 1262-72.
REFERENCES Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. 1996. Cloning of a
Amstead GM; Calson KE; Katzenellenbogen JA.
novel estrogen receptor expressed in rat
1997. The estradiol pharmacophore: ligand
prostate and ovary. Proc Natl Acad Sci USA
structure-estrogen receptor binding affinity
relationships and a model for the receptor
Bernheimer LB, Soskin S. 1942. Mechanism of
pharmacology. Maturitas 48 Suppl. 1 (S7-S12).
effect of estrogen on nasal mucosa in atrophic
Millas I, Liquidato BM, Dolci JEL, Macea JR,
rhinitis. Arch Otolaryngol 32: 57-9. Fregnani JHT, Meceles LR. 2010. Immuno-
Bhagu BR, Shui-Pang T, Xiao FL. 2008.Structure
histochemical evaluation of estrogen receptors
alpha and beta in normal inferior turbinate
interactions and functional activity of various
Millas I, Liquidato BM, Buck HS, Barros MD, Paes RAP, Dolci JEL. 2011. Evaluation of
estrogen receptors in the nasal mucosa of
Caruso S, Roccassalva C, Di Fazio E, Sapienza G, Agnello C, Ficarra S, Di Mari L, Serra A.
2003. Cytology aspects of the nasal respiratory
Mosselman S, Polman J, Dijkema R. 1996. ER
epithelium in post-menopausal women treated
beta: identification and characterization of a
with hormone therapy. Fertil Steril 79: 543-49.
novel human estrogen receptor. FEBS Lett
Enmark E, Gustafsson JA. 1999. Oestrogen
receptors - an overview. J Intern Med; 246:
Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson JA, Kushner PJ, Scanlan T. 1997.
Todos los derechos reservados. Reg. Nº: 5024555 www.anatclinar.com.ar
Action of estrogen receptors Rev Arg de Anat Clin; 2012, 4 (2): 65-69__________________________________________________________________________________________
Differential ligand activation of estrogen
Proceeding of the Society for Experimental
receptors ER and ER at AP1 Sites. Science
Shirasaki H, Watanabe K, Kanaizumi E. 2004.
Immunolocalization of estrogen receptor beta in
Expression and localization of steroid receptors
human tissues. J Mol Endocrinol 24: 145-55.
in human nasal mucosa. Acta Otolaryngol 124:
Tiwari-Woodruff S, Morales LBJ, Lee R, Voskuhi RR. 2007. Differential neuroprotective and anti-
Soskin S, Bernheimer CB. 1939. Mechanism of
inflammatory effects of estrogen receptor (ER)
Estrogen Effect on Nasal Mucosa in Atrophic
and ER ligand treatment. PNAS 104:
Rhinitis, successful treatment with Prostigmin.
Todos los derechos reservados. Reg. Nº: 5024555 www.anatclinar.com.ar
BECAS ESTÍMULO FLORENCIO FIORINI para INVESTIGACIÓN EN MEDICINA otorgadas con el auspicio de la Asociación Médica Argentina desde 2003 AÑO 2014 Beneficiario: Dr. Santiago Miguel Beltramino Proyecto: Ensayo clínico con asignación aleatoria para evaluar la eficacia del tratamiento con urea en la hiponatremia por síndrome de secreción inadecuada de hormona antidiurética. Instituci
SISTEMA MEXICANO DE INVESTIGACIÓN EN PSICOLOGÍA Cuarta Reunión Nacional de Investigación en Psicología 21 y 22 de junio de 2012 Consumo de café, actividad y comportamiento alimentario en ratas Virginia Gabriela Aguilera Cervantes, Antonio López-Espinoza, Alma Gabriela Martínez Moreno, Asucena Cárdenas-Villalvazo, Elia Herminia Valdez Miramontes y Claudia R. Magaña Gon